MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3899/jrheum.141128

Медицинская библиотека · The Journal of rheumatology · 2015

Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity.

Plasencia Chamaida, Kneepkens Eva L, Wolbink Gertjan, Krieckaert Charlotte L M, Turk Samina, Navarro-Compán Victoria, L'Ami Merel, Nurmohamed Mike T, van der Horst-Bruinsma Irene, Jurado Teresa, Diego Cristina, Bonilla Gema, Villalba Alejandro, Peiteado Diana, Nuño Laura, van der Kleij Desiree, Rispens Theo, Martín-Mola Emilio, Balsa Alejandro, Pascual-Salcedo Dora

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

To compare clinical outcomes, incidence of flares, and administered drug reduction between patients with spondyloarthritis (SpA) under TNF inhibitor (TNFi) tapering strategy with patients receiving a standard regimen.

METHODS

In this retrospective study, 74 patients with SpA from Spain on tapering strategy (tapering group; TG) were compared with 43 patients from the Netherlands receiving a standard regimen (control group; CG). The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) was measured at visit 0 (prior to starting the TNFi), visit 1 (prior to starting tapering strategy in TG and at least 6 months with BASDAI < 4 after starting the TNFi in the TG and CG), visit 2 (6 mos after visit 1), visit 3 (1 year after visit 1), and visit 4 (the last visit available after visit 1).

RESULTS

An overall reduction of the administered drug was seen at visit 4 in the TG [dose reduction of 22% for infliximab (IFX) and an interval elongation of 28.7% for IFX, 45.2% for adalimumab, and 51.5% for etanercept] without significant differences in the BASDAI between the groups at visit 4 (2.15 ± 1.55 in TG vs 2.11 ± 1.31 in CG, p = 0.883). The number of patients with flares was similar in both groups [22/74 (30%) in the TG vs 8/43 (19%) in the CG, p = 0.184].

CONCLUSION

The tapering strategy in SpA results in an important reduction of the drug administered, and the disease control remains similar to that of the patients with SpA receiving the standard regimen.

Для цитирования: Plasencia Chamaida, Kneepkens Eva L, Wolbink Gertjan, Krieckaert Charlotte L M, Turk Samina, Navarro-Compán Victoria, L'Ami Merel, Nurmohamed Mike T, van der Horst-Bruinsma Irene, Jurado Teresa, Diego Cristina, Bonilla Gema, Villalba Alejandro, Peiteado Diana, Nuño Laura, van der Kleij Desiree, Rispens Theo, Martín-Mola Emilio, Balsa Alejandro, Pascual-Salcedo Dora. Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity.. The Journal of rheumatology. 2015. DOI: 10.3899/jrheum.141128.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.